Browse EX-10 agreements

FIRST AMENDMENT TO CREDIT AGREEMENT

This First Amendment to Credit Agreement (this “Amendment”) is entered into by and among TEXAS CAPITAL BANK, a Texas state bank, as Administrative Agent, Collateral Agent and Issuing Bank, the Lenders under the Existing Credit Agreement (as defined below) that are signatories hereto, the New Lenders (as defined below) that are signatories hereto, and DBR LAND HOLDINGS LLC, a Delaware limited liability company, as Borrower, and is dated August 4, 2026 (the “First Amendment Effective Date”).

R E C I T A L S:

WHEREAS, the Borrower, the Administrative Agent, the Collateral Agent, the Issuing Bank and the Lenders are party to that certain Revolving Credit Agreement dated November 18, 2025 (as amended, restated, supplemented or otherwise modified prior to the date hereof, the “Existing Credit Agreement”, and the Existing Credit Agreement, as amended by this Amendment, the “Credit Agreement”); and

…

DUOLINGO, INC. AMENDED AND RESTATED​ NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM This Duolingo, Inc. (the “Company”) Amended and Restated Non-Employee Director Compensation Program (this “Program”) has been adopted under the Company’s 2021 Incentive Award Plan (the “Plan”) and, effective as of July 23, 2026 (the “Effective Date”), amends, restates and supersedes the Non-Employee Director Compensation Program in effect immediately prior to the Effective Date. Capitalized terms not otherwise defined herein shall have the meaning ascribed in the Plan. Cash Compensation As of the Effective Date, annual retainers will be paid in the following amounts to Non-Employee Directors: Board Service Non-Employee Director: $45,000 Non-Executive Chair/Lead Director: $47,500 Committee Service Chair Non-Chair Audit Committee Member $25,000 $10,000 Compensation Committee Member $20,000 $9,000 Nominating and Corporate Governance Committee Member $10,000 $5,000 Mergers and Acquisitions Committee Member $10,000 $5,000 All annual retainers are additive and, except to the extent of any Retainer RSU Election

…

---

[ ** ]

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

![](exhibit1

---

SECTION SF 30 BLOCK 14 CONTINUATION PAGE SUMMARY OF CHANGES Solicitation/Contract Form The following changes have been made: Supplies or Services & Prices or Costs The following changes to Limits have been made: [ ** ] [ ** ][ ** ] [ ** ] [ ** ] [ ** ] [ ** ]

---

Description/Specifications/Statement of Work The Requirements text has been modified to: Contract Clauses Miscellaneous text in this section has been modified to: CONTINUATION SHEET Delivery Information DELIVERY INFORMATION CLIN DELIVERY DATE QUANTITY SHIP TO ADDRESS DODAAC / CAGE 0001 POP 01-JAN- 2024 TO 30-SEP-2028 N/A JPM CBRN MEDICAL KEVIN WATTS [ ** ] [ ** ] [ ** ] [ ** ] [ ** ]

---

…

---

W911SR24D0001 W911SR24F0016P00005 Page 2 of 3 SECTION SF 30 BLOCK 14 CONTINUATION PAGE SUMMARY OF CHANGES SECTION SF 30 - BLOCK 14 CONTINUATION PAGE The following have been added by full text: P00005 The purpose of this modification is as follows: 1. To fully fund Option CLIN 1001 in the amount of to procure of BioThrax® AVA (Anthrax Vaccine Absorbed). 2. Pursuant to DFARS 252.232-7007, Limitation of Government’s Obligation, funding in the amount of is hereby added to Contract Line Item Number (CLIN) 1001 as shown in the table below. CLIN CLIN Amount Current Funding Total Funding Balance to be Funded 1001 $0.00 3. Except as provided herein, all terms and conditions remain unchanged. SECTION SF 1449 - CONTINUATION SHEET SUPPLIES OR SERVICES AND PRICES CLIN 0005 The manufacturer part number AVA has been deleted. The PSC code 6505 has been deleted. The PROG code C9E has been deleted. SUBCLIN 100103 is added as follows: [ ** ] [ ** ] [ ** ] [ ** ] [ ** ] [ ** ]

---

…

---

[ ** ]

---

[ ** ] [ ** ] [ ** ] [ ** ] [ ** ] [ ** ]

---

---

SF 30 BLOCK 14 CONTINUATION PAGE SUMMARY OF CHANGES Solicitation/Contract Form Continuation The following changes have been made: Miscellaneous text in this section has been modified to: Delivery Order 02 1. Delivery Order (DO) W911SR-26-F-A005 is awarded to Emergent Biodefense Operations Lansing LLC., to delivery of AVA doses. 2. This DO shall consist of a base and 2 option periods as follows Base Year: To be delivered before - 30 September 2026 Option Year 1: To be delivered before 30 September 2027 Option Year 2: To be delivered before 30 September 2028 [ ** ]

---

…

---

W911SR24D0001 P00001 Page 2 of 9 SECTION SF 30 BLOCK 14 CONTINUATION PAGE SUMMARY OF CHANGES SECTION SF 30 - BLOCK 14 CONTINUATION PAGE The following have been added by full text: P00001 The purpose of this modification is to: 1. Insert Commercial Clause 52.222-54. All other terms and conditions remain the same in full force and effect SECTION SF 1449 - CONTINUATION SHEET SOLICITATION/CONTRACT FORM The vendor signature required has changed from required to not required. The number of award copies required 1 has been deleted. The following have been modified: 52.212-5 CONTRACT TERMS AND CONDITIONS REQUIRED TO IMPLEMENT STATUTES OR EXECUTIVE ORDERS--COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (JUN 2023) (a) The Contractor shall comply with the following Federal Acquisition Regulation (FAR) clauses, which are incorporated in this contract by reference, to implement provisions of law or Executive orders applicable to acquisitions of commercial products and commercial services: (1) 52.203-19, Prohibition on Requiring Certain Internal Confiden

…

---

SF 30 BLOCK 14 CONTINUATION PAGE SUMMARY OF CHANGES Solicitation/Contract Form Continuation The following changes have been made: Miscellaneous text in this section has been modified to: Delivery Order 02 1. Delivery Order (DO) W911SR-26-F-A005 is awarded to Emergent Biodefense Operations Lansing LLC., to delivery of AVA doses. 2. This DO shall consist of a base and 2 option periods as follows Base Year: To be delivered before - 30 September 2026 Option Year 1: To be delivered before 30 September 2027 Option Year 2: To be delivered before 30 September 2028 3. Pursuant to DFAR 252.232-7007, Limitation of Government's Obligation, initial funding will be obligated in the amount of . 4. Items will be delivered on or before 30 September 2026 to: MUrtech Inc. 820 Cromwell Park Dr, STE J Glen Burnie MD 21061-2574 [ ** ]

---

…

                            

…

---

[ ** ] [ ** ] [ ** ]

---

---

LNG SALE AND PURCHASE AGREEMENT

(CNRL)

Dated    August 4, 2026

BETWEEN

CORPUS CHRISTI LIQUEFACTION, LLC

(Seller)

AND

CHENIERE MARKETING INTERNATIONAL LLP

(Buyer)

---

Table of Contents

Page No.

1.										Definitions and Interpretation	1
1.1										Definitions	1
1.2										Interpretation	17

…